Evaluation of pre-exposure vaccine effectiveness against mpox during the 2022–2023 mpox outbreak in the Madrid region (Spain): a test-negative design
Introduction An appropriate vaccination approach is critical to control the current outbreak of mpox but there is little research providing information on its effectiveness, particularly under circumstances of limited vaccine availability.Methods Pre-exposure vaccination campaign in the Madrid regio...
Saved in:
| Main Authors: | José Francisco Barbas del Buey, Jesús Íñigo Martínez, Marcos Alonso García, Andrés Aragón Peña, Laura Montero Morales, Araceli Arce Arnáez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-04-01
|
| Series: | BMJ Public Health |
| Online Access: | https://bmjpublichealth.bmj.com/content/2/1/e000620.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nowcasting the 2022 mpox outbreak in England.
by: Christopher E Overton, et al.
Published: (2023-09-01) -
The first case of Mpox infection in Iran during the 2022 outbreak
by: Ali Maleki, et al.
Published: (2024-09-01) -
Mpox Cases in Serbia, 2022
by: Petar Đurić, et al.
Published: (2025-01-01) -
Building systems’ resilience in the mpox outbreak response in Africa
by: Ngashi Ngongo, et al.
Published: (2025-03-01) -
Clade Ib: a new emerging threat in the Mpox outbreak
by: Shriyansh Srivastava, et al.
Published: (2024-12-01)